Drug Pipeline

Rocatinlimab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
2
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05882877 A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult… Atopic Dermatitis Active, Not Recruiting
NCT06527404 A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo… Prurigo Nodularis Active, Not Recruiting
Phase 2
NCT06376045 A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma Asthma Active, Not Recruiting
Sponsors Running Rocatinlimab Trials
Amgen (3)
Disease Areas
Atopic Dermatitis (1) Asthma (1)
Get alerts when Rocatinlimab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free